FIT screening

Colorectal cancer (CRC) is one of the most frequently diagnosed cancers. The good news is that CRC incidence and mortality can be reduced significantly if detected early enough.

Faecal immunochemical tests (FIT) are non-invasive and can detect blood in stool invisible to the naked eye. Due to its simplicity, FIT is currently considered the best non-invasive test for CRC screening.

Invest a little time in your own health by taking the FIT to prevent or detect colon cancer early on.
For further information, please visit our ‘FIT for screening’ website www.fitscreening.eu/patients

July - Molecular detection of marker genes

Highly sensitive and specific amplification technologies enable targeted detection of molecular markers for diagnostic purposes. OSNA® (One Step Nucleic Acid Amplification) utilises RT-LAMP* to detect CK19 mRNA for the presence / absence of metastases in lymph nodes. Lymph node status is the most important prognostic factor in most cancer entities and important information for guiding treatment decisions.


* Reverse Transcription Loop-mediated Isothermal Amplification; Licensed under agreement with EIKEN Chemical Co., Ltd.

Scientific Calendar 2017

Oncology Overview

Go back to the overview of Oncology

Click Here

Solution for detection of lymph node metastases

Enjoy our Media Center
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos
Company movie
See our collection
See our collection https://www.sysmex.dk/academy.html
Grow your knowledge https://www.sysmex.dk/academy.html
See our collection https://www.sysmex.dk/academy.html
See our library of smears https://www.sysmex.dk/academy/library/image-gallery.html
Learn more about our concept https://www.sysmex.dk/company/who-is-sysmex/silent-design.html